Literature DB >> 23415297

Association of chronic kidney disease with adverse outcomes - Authors' reply.

Bakhtawar K Mahmoodi, Caroline S Fox, Brad C Astor, Robert G Nelson, Kunihiro Matsushita, Josef Coresh.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23415297      PMCID： PMC4769859          DOI： 10.1016/S0140-6736(13)60273-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease.

Authors:  Csaba P Kovesdy; Bhairvi K Trivedi; Kamyar Kalantar-Zadeh; John E Anderson
Journal:  Nephrol Dial Transplant       Date:  2006-01-18       Impact factor: 5.992

2.  Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study.

Authors:  L A Cupples; R B D'Agostino; K Anderson; W B Kannel
Journal:  Stat Med       Date:  1988 Jan-Feb       Impact factor: 2.373

3.  Systolic blood pressure and mortality among older community-dwelling adults with CKD.

Authors:  Jessica W Weiss; Eric S Johnson; Amanda Petrik; David H Smith; Xiuhai Yang; Micah L Thorp
Journal:  Am J Kidney Dis       Date:  2010-10-20       Impact factor: 8.860

Review 4.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.

Authors:  Bakhtawar K Mahmoodi; Kunihiro Matsushita; Mark Woodward; Peter J Blankestijn; Massimo Cirillo; Takayoshi Ohkubo; Peter Rossing; Mark J Sarnak; Bénédicte Stengel; Kazumasa Yamagishi; Kentaro Yamashita; Luxia Zhang; Josef Coresh; Paul E de Jong; Brad C Astor
Journal:  Lancet       Date:  2012-09-24       Impact factor: 79.321
  4 in total
  3 in total

Review 1.  Chronic kidney disease induced dysfunction of high density lipoprotein.

Authors:  Suguru Yamamoto; Valentina Kon
Journal:  Clin Exp Nephrol       Date:  2013-09-10       Impact factor: 2.801

2.  Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype.

Authors:  Suguru Yamamoto; Jiayong Zhong; Patricia G Yancey; Yiqin Zuo; MacRae F Linton; Sergio Fazio; Haichun Yang; Ichiei Narita; Valentina Kon
Journal:  Atherosclerosis       Date:  2015-07-04       Impact factor: 5.162

Review 3.  Diabetic nephropathy: What does the future hold?

Authors:  R M Montero; A Covic; L Gnudi; D Goldsmith
Journal:  Int Urol Nephrol       Date:  2015-10-05       Impact factor: 2.370
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.